The Canadian government report offered additional data which, if corroborated, could have prevented U.S. FDA from approving rBGH for injection into cows. It is evident from the Canadian report that the U.S. approval process for this drug was equally flawed. FDA has vigorously resisted all efforts by citizens, under the federal Freedom of Information Act, to obtain a copy of the complete study including the raw data. If John Scheid of FDA is right, FDA could not release the study because, Scheid says, FDA has never possessed a complete copy of the study. Health Canada is the Canadian equivalent of the U.S. Food and Drug Administration.
Subscriptions are free.
We would like to continue to provide this service free. Please do not send credit card information via E-mail.